Wednesday, December 1 | 9:30 a.m.-10:30 a.m. | SSRO03-2 | Room TBA
In this presentation, researchers from the University of Alabama at Birmingham will look at the effects of radiotherapies on vaginal bleeding for women with gynecological tumors.Luke Moradi, a medical student at the university, will present the team's findings, which examined the use of hypofractionated radiation therapy and conventionally fractionated radiation in controlling such bleeding. The group retrospectively looked at data from 44 patients.
The researchers found that patients who received hypofractionated radiation therapy saw their bleeding stop, on average, more quickly than those who received conventionally fractionated radiation.
"For patients with significant vaginal bleeding, initiation of hypofractionated radiation therapy to control malignancy related bleeding quickly may be warranted," the study authors noted.













![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






